Drug of choice for hyperthyroidism in pregnant female:
**Core Concept**
The management of hyperthyroidism in pregnant females requires careful consideration due to the potential effects on both the mother and the fetus. In pregnancy, the primary goal is to control thyroid hormone levels while minimizing the risk of fetal hypothyroidism and other complications.
**Why the Correct Answer is Right**
The preferred treatment for hyperthyroidism in pregnant females is **methimazole (MMI)**. MMI is a thionamide antithyroid drug that inhibits thyroid hormone synthesis by targeting the enzyme **thyroid peroxidase (TPO)**. This mechanism is crucial in preventing the release of pre-formed thyroid hormones, thereby reducing the risk of fetal hypothyroidism. MMI is generally considered safer than other antithyroid medications, such as **propylthiouracil (PTU)**, during the first trimester of pregnancy due to a lower risk of birth defects.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because **sotalol**, a beta-blocker, is used to control the symptoms of hyperthyroidism, such as tachycardia, but it does not address the underlying cause of the condition.
* **Option B:** This option is incorrect because **iodine**, although used in some cases to treat hyperthyroidism, is not the preferred treatment in pregnant females due to the risk of iodine-induced hyperthyroidism in the fetus.
* **Option C:** This option is incorrect because **radioactive iodine**, which is used to ablate the thyroid gland, is contraindicated in pregnancy due to the risk of fetal thyroid ablation.
**Clinical Pearl / High-Yield Fact**
It is essential to note that patients with hyperthyroidism should be closely monitored for signs of thyroid storm, which can be precipitated by surgery, trauma, or other stresses. A high index of suspicion and prompt treatment are crucial in preventing this life-threatening complication.
**Correct Answer: C. Methimazole**